Venture capitalists hit the ground running after returning from their summer vacations that saw third-quarter investments fall substantially from the first half. (See BioWorld Today, Oct. 2, 2015.)
Perhaps "sprint" might be a better verb.
After funding just 39 U.S. companies tracked by BioWorld Snapshots in the third quarter, there were 62 deals in the fourth quarter, more than the 53 and 50 seen in the first and second quarter respectively.
The grand total of 204 deals in 2015 raised a whopping $7.63 billion for private companies. By comparison, 2014 had 163 deals that raised $3.85 billion.
Across the board, each stage of funding rounds saw increases in the number of deals and the amount raised with the exception of series B rounds where the number of deals decreased from 56 in 2014 to 49 in 2015. Despite the drop, companies receiving their second round of financing in 2015 raised $712 million more than their 2014 peers. The